Benfotiamine shows up in “nerve support” formulas, in blood sugar products, and increasingly in general B-vitamin stacks. It’s often described as a “super B1.” That label has some basis in chemistry, but the clinical evidence behind it is much less certain than the marketing suggests.
Here’s what’s known, what’s still unclear, and who might reasonably consider it.
What benfotiamine is
Benfotiamine is a synthetic derivative of thiamine (vitamin B1). Standard thiamine supplements use water-soluble salts, usually thiamine hydrochloride or thiamine mononitrate. Absorption of those salts is limited by transporters in the gut, so taking more gives diminishing returns.
Benfotiamine is converted in the gut into a more fat-soluble form that crosses membranes more easily. It is then turned back into thiamine in the body. Pharmacokinetic studies consistently show that benfotiamine produces higher and longer-lasting blood thiamine levels than the same dose of thiamine hydrochloride.
That part is well established. The harder question is whether higher thiamine levels lead to meaningful health benefits in people who aren’t deficient.
For the basics of thiamine itself, see our thiamine guide and the vitamin B1 supplement page.
Why researchers got interested
Thiamine is a cofactor for enzymes that process glucose. One of these, transketolase, helps divert excess glucose byproducts into less harmful pathways. In laboratory and animal studies, benfotiamine increased transketolase activity and reduced the buildup of compounds such as advanced glycation end products (AGEs), which are thought to play a role in damage to nerves, blood vessels, and kidneys when blood sugar stays high.
That mechanism made benfotiamine a natural candidate for studies in people with diabetes, especially for nerve-related symptoms in the feet and hands. It’s a reasonable hypothesis. But a mechanism shown in cells and animals doesn’t guarantee a clinical benefit in people.
What human studies show
The human evidence is small and mixed.
Nerve discomfort in diabetes. Several short, small randomized trials in people with diabetes-related nerve symptoms reported improvements in symptom scores (such as tingling or pain ratings) with benfotiamine, sometimes in combination with other B vitamins, compared with placebo. These trials were typically a few weeks to a few months long, with modest numbers of participants. Some reported benefits only on certain measures.
Other trials, including at least one that ran longer and measured objective nerve function, did not find clear differences from placebo in nerve conduction or other markers.
Vascular and kidney markers. Some studies looked at markers of blood vessel function or kidney-related changes. Results were inconsistent, and several found no meaningful change.
Other uses. Benfotiamine is being explored for brain health and for alcohol-related thiamine problems. The research here is early and mostly limited to small pilot studies. It’s too soon to draw conclusions.
Taken together, the evidence suggests benfotiamine may help some people with nerve-related symptoms, but the effect isn’t consistent, and the studies are too small and short to be confident. Our guide on how to read supplement research explains why small, short trials deserve caution.
Who is most likely to be low in thiamine
Benfotiamine is most relevant as a question of whether someone is actually low in thiamine. Groups at higher risk include:
- Heavy alcohol users. Alcohol reduces thiamine absorption and storage. Severe deficiency in this group is a medical emergency, and it’s treated by clinicians, usually with injections, not supplements.
- People after bariatric surgery. Reduced absorption and food intake can cause deficiency.
- Older adults with poor appetite or limited diets.
- People on some diuretics, especially loop diuretics like furosemide, which increase thiamine loss in urine.
- People with poorly controlled diabetes. Some research suggests they lose more thiamine in urine.
- People on long-term metformin are known to have lower B12. Thiamine isn’t the main concern there, but it’s a good reason to review B-vitamin status in general. See Metformin and Vitamin B12.
If you fall into one of these groups, it’s worth talking to a clinician about testing rather than self-treating.
Dosing
Studies have typically used 150-600 mg of benfotiamine per day, often split into two doses with meals. Many commercial products contain 150-300 mg per capsule.
Some context: the RDA for thiamine is only 1.1 mg/day for women and 1.2 mg/day for men. Benfotiamine doses are therefore hundreds of times the daily requirement. No tolerable upper limit has been set for thiamine because toxicity from food or standard supplements hasn’t been observed. But benfotiamine is a different compound, and its long-term safety at high doses hasn’t been studied as thoroughly.
Practical notes:
- Take it with food, which may reduce stomach upset.
- Starting at the low end (150 mg/day) and discussing higher doses with a clinician is sensible.
- Don’t use benfotiamine in place of medical care for nerve symptoms. Numbness, tingling, or burning in the feet or hands needs a proper evaluation, because there are many possible causes.
Safety
In the studies available, benfotiamine was generally well tolerated. Reported side effects were uncommon and mild: stomach upset, nausea, and occasionally skin rash.
Points to consider:
- Pregnancy and nursing: there’s no good safety data at supplement doses. Stick to a prenatal vitamin unless your provider advises otherwise.
- Diabetes medications: benfotiamine isn’t known to lower blood sugar directly, but anyone managing diabetes should tell their care team about every supplement they take.
- Combination products: many “nerve support” formulas also contain high-dose vitamin B6. Long-term high B6 intake has been linked to nerve problems itself, which is the opposite of what these products promise. Check the label and keep total B6 within the upper limit.
- Unverified products: choose brands that use third-party testing, since supplement quality varies.
Bottom line
Benfotiamine is a better-absorbed form of vitamin B1, and that part of the story is solid. Evidence that it improves nerve-related symptoms in people with diabetes is mixed and based on small, short studies. It appears low-risk at studied doses (150-600 mg/day), so it can be reasonable to try with medical guidance, but it’s not a proven treatment and shouldn’t replace evaluation of nerve symptoms.
This article is educational and not medical advice. Consult a healthcare provider before starting any supplement, especially if you are pregnant, nursing, on medication, or managing a health condition.